On Friday, February 8, AstraZeneca Pharmaceuticals LP and Torrent Pharmaceuticals Ltd. settled a patent infringement suit over AstraZeneca’s anti-depressant drug Seroquel XR®. In the settlement, Torrent agreed not to produce a generic version of Seroquel XR® until November 2016. Finnegan represented AstraZeneca in this matter.